This document discusses WE Oncology, a cancer diagnostic and treatment center located in Dallas, TX. It offers medical and surgical treatments, radiation therapy, and focuses on blood cancers like leukemia and lymphoma. The center aims to improve its diagnostic rates of benign and malignant blood tumors. Its goals for the future are to become the leading diagnostic center in Texas within 5-7 years and one of the top requested centers for cancer care, treatment, and diagnosis in America. The document also evaluates two new medical imaging technologies: Revolution CT, which enables lower-dose 4D imaging but risks artifacts and difficulties with some patients, and Multitom Rax, which performs multiple 3D x-rays with less radiation than normal but has uncertainties around future